Revenue Increases 382% Year-Over-Year to
Financial Summary:
| Three Months Ended | Nine Months Ended | ||
(in thousands of Canadian dollars, except per share amounts) | 2026 | 2025 | 2026 | 2025 |
Revenue | 41,889 | 8,695 | 110,278 | 23,795 |
Income from mining operations | 25,984 | 1,254 | 65,097 | 1,062 |
General and administrative expenses | 11,634 | 3,772 | 27,626 | 11,266 |
Net income (loss) for the period | 50,235 | 33,191 | 226,768 | (59,640) |
Earnings (loss) per share – basic | ||||
Earnings (loss) per share – diluted | ||||
Adjusted EBITDA (Non-IFRS) | 14,586 | (2,285) | 38,279 | (9,412) |
Key Third Quarter 2026 & Subsequent Operational Highlights
The Sangdong Mine produced its first tungsten concentrate inSeptember 2026 , the first tungsten produced at the site since 1993, and subsequent to quarter end, the first container of Sangdong concentrate was loaded at the port ofBusan for shipment to an overseas customer. More than 90% of Phase I production is contracted under the Company’s long-term offtake agreement withGlobal Tungsten & Powders LLC (“GTP”), a member of Austria’sPlansee Group . The agreement was amended inJuly 2026 to extend the term by six years, increase total contracted volumes by 40% and improve pricing on all contracted volumes by approximately 6.3%.- In
September 2026 , Almonty confirmed that it is proceeding with the fully permitted Phase II expansion of theSangdong Mine , which is expected to increase throughput capacity to up to 1.2 million tonnes per year, and placed orders for Phase II equipment. Subject to Phase I operating performance and prevailing market conditions, Phase II is targeted for completion in 2027. - During the quarter, Almonty signed a multi-year, take-or-pay supply agreement with a large-scale European customer, covering a minimum of approximately 1,720 tonnes of contained WO3 to be recovered from retreatment of the existing tailings inventory at the
Los Santos Mine inSpain . - Almonty also entered into a binding agreement with the
Government of Rwanda , which will receive a 25% interest inAlmonty Rwanda Pty Ltd (“Almonty Rwanda”) in exchange for contributing the Shyorongi tungsten exploration concession and granting a mineral processing license for a mobile tailings processing unit to acquire and export ore, pre-concentrate and panning tailings. Almonty Rwanda launched last month with purchase contracts to export more than 100 tonnes of tungsten ore per month. - On
August 24, 2026 , Almonty commenced a share repurchase program for up to 14.4 million common shares, for an aggregate purchase price of up toUS$300 million , over a 36-month period. During the third quarter, the Company repurchased and cancelled 2,914,739 common shares at a weighted average price ofUS$16.58 per share and, subsequent to quarter end, repurchased and cancelled an additional 703,053 common shares.
Management Commentary
“All the while, Panasqueira continued to generate strong margins, delivering
“Beginning
Third Quarter 2026 Financial Results Highlights
Revenue in the third quarter of 2026 increased 382% to
Income from mining operations in the third quarter of 2026 was
General and administrative expenses in the third quarter of 2026 totaled
Net income in the third quarter of 2026 was
Adjusted EBITDA, a non-IFRS measure, was
Cash as of
About Almonty
Almonty (Nasdaq: ALM) (Frankfurt: ALI1) is a leading supplier of conflict-free tungsten, a strategic metal critical to the defense and advanced technology sectors. As geopolitical tensions heighten, tungsten has become essential for armor, munitions, and electronics manufacturing. Almonty’s flagship Sangdong Tungsten Mine in
Legal Notice
The release, publication, or distribution of this announcement in certain jurisdictions may be restricted by law and therefore persons in such jurisdictions into which this announcement is released, published, or distributed should inform themselves about and observe such restrictions.
Use of Non-IFRS Financial Measures
This news release makes reference to the non-IFRS financial measure “Adjusted EBITDA”. Non-IFRS financial measures are not recognized measures under IFRS, do not have a standardized meaning prescribed by IFRS and may not be comparable to similar measures presented by other companies. Rather, these measures are provided as additional information to complement IFRS financial measures by providing further understanding of Almonty’s results of operations from management’s perspective. Almonty’s definitions of non-IFRS measures, including the definition of the non-IFRS financial measure “Adjusted EBITDA” used in this news release, may not be the same as the definitions for such measures used by other companies in their reporting. Non-IFRS measures have limitations as analytical tools and should not be considered in isolation nor as a substitute for analysis of Almonty’s financial information reported under IFRS. Almonty uses non-IFRS financial measures, including “Adjusted EBITDA”, to provide investors with supplemental measures of its operating performance and to eliminate items that have less bearing on operating performance or operating conditions, and thus highlight trends in its core business that may not otherwise be apparent when relying solely on IFRS financial measures. In particular, Almonty’s management uses Adjusted EBITDA in order to evaluate its operating performance, by eliminating the impact of non-operational or non-cash items. Almonty believes that securities analysts, investors and other interested parties frequently use non-IFRS financial measures in the evaluation of issuers. Almonty’s management also uses non-IFRS financial measures in order to facilitate operating performance comparisons from period to period.
IFRS NET INCOME (LOSS) TO ADJUSTED EBITDA RECONCILIATION
| Three Months Ended | Nine Months Ended | ||
(in thousands of Canadian dollars) | 2026 | 2025 | 2026 | 2025 |
Net income (loss) for the period | 50,235 | 33,191 | 226,768 | (59,640) |
Depreciation & amortization | 236 | 233 | 808 | 792 |
(Gain) loss on valuation of embedded derivative liabilities | (104,668) | 288 | (302,683) | 10,139 |
Loss on valuation of embedded derivative asset | 57,075 | – | 87,758 | – |
(Gain) loss on valuation of warrant liabilities | (355) | (34,513) | 2,253 | 29,381 |
Foreign exchange (gain) loss | (7,567) | (3,338) | (10,065) | (1,924) |
Taxes | 6,621 | 163 | 15,612 | 197 |
Interest, net | 12,782 | 964 | 12,849 | 3,292 |
Share-based compensation | 227 | 727 | 4,979 | 8,351 |
Adjusted EBITDA (Non-IFRS) | 14,586 | (2,285) | 38,279 | (9,412) |
Cautionary Note Regarding Forward-Looking Information
This news release contains “forward-looking statements” and “forward-looking information” within the meaning of applicable securities laws. All statements, other than statements of present or historical facts, are forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and assumptions and accordingly, actual results could differ materially from those expressed or implied in such statements. You are hence cautioned not to place undue reliance on forward-looking statements. Forward-looking statements are typically identified by words such as “plan”, “development”, “growth”, “continued”, “intentions”, “expectations”, “emerging”, “evolving”, “strategy”, “opportunities”, “anticipated”, “trends”, “potential”, “outlook”, “ability”, “additional”, “on track”, “prospects”, “viability”, “estimated”, “reaches”, “enhancing”, “strengthen”, “target”, “believes”, “next steps” or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking statements in this news release include, but are not limited to, statements concerning the commissioning and ramp-up of Phase I of the
Forward-looking statements are based upon certain assumptions and other important factors that, if untrue, could cause actual results to be materially different from future results expressed or implied by such statements. There can be no assurance that forward-looking statements will prove to be accurate. Key assumptions upon which the Company’s forward-looking information is based include, without limitation, the successful ramp-up of Phase I of the
Although Almonty has attempted to identify important factors that could cause actual results, level of activity, performance or achievements to differ materially from those contained in forward-looking statements, the foregoing list of material factors is not exhaustive, and there may be other factors that could cause results, level of activity, performance or achievements not to be as anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, and even if events or results described in the forward-looking statements are realized or substantially realized, there can be no assurance that they will have the expected consequences to, or effects on, Almonty. Accordingly, readers should not place undue reliance on forward-looking statements and are cautioned that actual outcomes may vary. When relying on Almonty’s forward-looking statements and information to make decisions, investors and others should carefully consider the foregoing factors and other uncertainties and potential events. Almonty has also assumed that material factors will not cause any forward-looking statements and information to differ materially from actual results or events. However, the list of these factors is not exhaustive and is subject to change and there can be no assurance that such assumptions will reflect the actual outcome of such items or factors.
THE FORWARD-LOOKING INFORMATION CONTAINED IN THIS NEWS RELEASE REPRESENTS THE EXPECTATIONS OF ALMONTY AS OF THE DATE OF THIS NEWS RELEASE AND, ACCORDINGLY, IS SUBJECT TO CHANGE AFTER SUCH DATE. READERS SHOULD NOT PLACE UNDUE IMPORTANCE ON FORWARD-LOOKING INFORMATION AND SHOULD NOT RELY UPON THIS INFORMATION AS OF ANY OTHER DATE. WHILE ALMONTY MAY ELECT TO, IT DOES NOT UNDERTAKE TO UPDATE THIS INFORMATION AT ANY PARTICULAR TIME, WHETHER AS A RESULT OF NEW INFORMATION, FUTURE EVENTS OR OTHERWISE, EXCEPT AS REQUIRED IN ACCORDANCE WITH APPLICABLE LAWS.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261112612204/en/
Company Contact
Chairman, President & CEO
(647) 438-9766
info@almonty.com
Investor Relations Contact
Managing Director
(949) 259-4987
ALM@mzgroup.us
www.mzgroup.us
Source: